IGF-1 DES
Des(1-3) IGF-1 · Short-acting IGF-1
Half-life
20 min
Time to Peak
6 min
Steady State
~1 days
Dose Range
20–100 mcg
Frequency
Daily
Overview
Truncated form of IGF-1 missing the first three N-terminal amino acids (des-1-3-IGF-1). This modification increases potency (~10x more potent than native IGF-1) but dramatically shortens half-life to ~20 minutes due to reduced IGFBP binding. Used for localized, site-specific muscle growth when injected directly into target tissue. Requires reconstitution with BAC water.
Mechanism of Action
Hyper-potent IGF-1 receptor agonist. Reduced IGFBP binding means rapid action but very short duration. Used for localized tissue growth when injected site-specifically.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Subcutaneous (SubQ) | 20–100 mcg | 20 min | 6 min | Daily, pre workout |
Storage & Handling
2-8C — Store lyophilized powder frozen or refrigerated. Reconstitute with BAC water. Very short-acting — typically injected into target muscle immediately pre/post-workout.
Used in Regimens
IGF-1 DES is not currently part of any catalog regimen.
Data Sources
- Peer-reviewed Des(1-3) IGF-1 potency and pharmacokinetics
Related Tools
Track IGF-1 DES with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.